|
G
|
Csf3
|
colony stimulating factor 3
|
treatment
|
ISO
|
associated with Graves Disease; associated with Multiple Myeloma;
|
RGD |
PMID:8935143 PMID:15785251 |
RGD:11039034 RGD:11039041 |
NCBI chrNW_004624795:3,162,999...3,167,248
Ensembl chrNW_004624795:3,163,009...3,166,594
|
|
G
|
Il1b
|
interleukin 1 beta
|
treatment
|
ISO
|
associated with Glioblastoma;
|
RGD |
PMID:1331350 |
RGD:10450883 |
NCBI chrNW_004624749:12,852,128...12,858,478
Ensembl chrNW_004624749:12,852,021...12,858,760
|
|
G
|
Il1rn
|
interleukin 1 receptor antagonist
|
|
ISO
|
associated with Leukemia;protein:decreased expression:serum:
|
RGD |
PMID:8698137 |
RGD:11528539 |
NCBI chrNW_004624749:13,210,365...13,224,471
Ensembl chrNW_004624749:13,210,476...13,225,890
|
|
|
G
|
Ace
|
angiotensin I converting enzyme
|
severity
|
ISO
|
DNA:deletion:intron:IVS16+1464-1751del (human) associated with acute leukemia;DNA:insertion/deletion:intron 16:
|
RGD |
PMID:15806540 PMID:24819208 |
RGD:11038917 RGD:11530041 |
NCBI chrNW_004624849:998,262...1,019,305
Ensembl chrNW_004624849:998,277...1,019,521
|
|
G
|
Fcgr3a
|
Fc fragment of IgG receptor IIIa
|
treatment
|
ISO
|
associated with Lymphoma, Large B-Cell, Diffuse;DNA:SNP: :rs396991 (human)
|
RGD |
PMID:27282998 |
RGD:11344967 |
NCBI chrNW_004624826:51,387...59,117
|
|
G
|
Itpa
|
inosine triphosphatase
|
|
ISO
|
associated with Precursor Cell Lymphoblastic Leukemia-Lymphoma;DNA:SNP: :rs41320251 (human)
|
RGD |
PMID:18685564 |
RGD:10766478 |
NCBI chrNW_004624741:4,312,363...4,341,996
Ensembl chrNW_004624741:4,312,360...4,325,825
|
|
G
|
Mbl2
|
mannose binding lectin 2
|
susceptibility disease progression
|
ISO
|
associated with leukemia; associated with Precursor B-Cell Lymphoblastic Leukemia-Lymphoma;DNA:polymorphisms:exon: associated with Neoplasms;DNA:SNP,haplotyep:promoter:
|
RGD |
PMID:20930093 PMID:24453114 PMID:24819208 |
RGD:11530041 RGD:11530043 RGD:11530056 |
NCBI chrNW_004624791:10,881,319...10,886,294
Ensembl chrNW_004624791:10,881,268...10,886,297
|
|
G
|
Tp53
|
tumor protein p53
|
susceptibility
|
ISO
|
associated with Breast Neoplasms;DNA:SNP:cds: p.R72P(rs1042522)(human)
|
RGD |
PMID:21706156 |
RGD:11073725 |
NCBI chrNW_004624786:10,266,316...10,282,664
Ensembl chrNW_004624786:10,263,518...10,271,218
|
|
|
G
|
Abcc2
|
ATP binding cassette subfamily C member 2
|
no_association susceptibility
|
ISO
|
associated with neoplasm;DNA:SNP:rs12762549(human)
|
RGD |
PMID:18294295 PMID:23188068 |
RGD:11080980 RGD:11080999 |
NCBI chrNW_004624737:11,593,701...11,686,790
Ensembl chrNW_004624737:11,593,864...11,688,460
|
|
G
|
Csf3
|
colony stimulating factor 3
|
treatment
|
ISO
|
associated with Hepatitis C, Chronic; associated with Leukemia, Hairy Cell;
|
RGD |
PMID:2461131 PMID:17660602 |
RGD:11039035 RGD:11039036 |
NCBI chrNW_004624795:3,162,999...3,167,248
Ensembl chrNW_004624795:3,163,009...3,166,594
|
|
G
|
Ercc1
|
ERCC excision repair 1, endonuclease non-catalytic subunit
|
treatment
|
ISO
|
associated with Colorectal Neoplasms;DNA:SNP
|
RGD |
PMID:23543295 |
RGD:11340199 |
NCBI chrNW_004624907:2,288,380...2,298,909
Ensembl chrNW_004624907:2,288,423...2,298,373
|
|
G
|
Ercc2
|
ERCC excision repair 2, TFIIH core complex helicase subunit
|
treatment
|
ISO
|
associated with Urinary Bladder Neoplasms;DNA:SNP: :p.K751Q (rs13181) (human)
|
RGD |
PMID:21047201 |
RGD:11098572 |
NCBI chrNW_004624907:2,249,323...2,263,999
Ensembl chrNW_004624907:2,250,133...2,263,947
|
|
G
|
Ercc6
|
ERCC excision repair 6, chromatin remodeling factor
|
treatment
|
ISO
|
associated with lung non-small cell carcinoma;DNA:SNP:intron: (rs4253212) (human)
|
RGD |
PMID:28924235 |
RGD:153323316 |
NCBI chrNW_004624928:458,651...532,201
Ensembl chrNW_004624928:463,279...530,115
|
|
G
|
Fcgr3a
|
Fc fragment of IgG receptor IIIa
|
|
ISO
|
associated with Lymphoma, B-Cell;DNA:polymorphism: :p.V158F (human) associated with Non-Hodgkin lymphoma;DNA:polymorphism: :p.V158F (human) associated with Lymphoma, Large B-Cell, Diffuse;DNA:polymorphism: :p.V158F (human)
|
RGD |
PMID:19933905 PMID:20730791 PMID:21883784 |
RGD:11344964 RGD:11344973 RGD:11352256 |
NCBI chrNW_004624826:51,387...59,117
|
|
G
|
Il1a
|
interleukin 1 alpha
|
treatment
|
ISO
|
associated with Carcinoma, Non-Small-Cell Lung
|
RGD |
PMID:7666093 |
RGD:11051963 |
NCBI chrNW_004624749:12,795,967...12,805,658
Ensembl chrNW_004624749:12,795,946...12,805,154
|
|
G
|
LOC101703821
|
HLA class II histocompatibility antigen, DQ beta 1 chain
|
|
ISO
|
|
RGD |
PMID:27400856 |
RGD:14928329 |
NCBI chrNW_004624754:23,895,509...23,902,487
Ensembl chrNW_004624754:23,895,607...23,906,713
|
|
G
|
Pold1
|
DNA polymerase delta 1, catalytic subunit
|
treatment
|
ISO
|
associated with lung non-small cell carcinoma; DNA:SNPs:exon, introns: (rs1726801, rs1673041, rs3219341) (human)
|
RGD |
PMID:28924235 |
RGD:153323316 |
NCBI chrNW_004624832:4,117,597...4,135,092
Ensembl chrNW_004624832:4,117,341...4,135,035
|
|
G
|
Sod2
|
superoxide dismutase 2
|
susceptibility
|
ISO
|
associated with female breast cancer;DNA:missense mutation:cds:p.V16A (rs4880) (human)
|
RGD |
PMID:20309628 |
RGD:11035278 |
NCBI chrNW_004624855:3,260,800...3,271,864
Ensembl chrNW_004624855:3,260,809...3,271,367
|
|
G
|
Tp53
|
tumor protein p53
|
susceptibility
|
ISO
|
associated with Small Cell Lung Carcinoma;DNA:SNP:: rs1042522(human)
|
RGD |
PMID:24732641 |
RGD:11073715 |
NCBI chrNW_004624786:10,266,316...10,282,664
Ensembl chrNW_004624786:10,263,518...10,271,218
|
|